Foxa3 induces goblet cell metaplasia and inhibits innate antiviral immunity

Gang Chen, Thomas R. Korfhagen, Christopher L. Karp, Soren Impey, Yan Xu, Scott H. Randell, Joseph Kitzmiller, Yutaka Maeda, Hans Michael Haitchi, Anusha Sridharan, Albert P. Senft, Jeffrey A. Whitsett

Research output: Contribution to journalArticle

64 Scopus citations

Abstract

Rationale: Goblet cell metaplasia accompanies common pulmonary disorders that are prone to recurrent viral infections. Mechanisms regulating both goblet cell metaplasia and susceptibility to viral infection associated with chronic lung diseases are incompletely understood. Objectives:Wesought to identify the role of the transcription factor FOXA3 in regulation of goblet cell metaplasia and pulmonary innate immunity. Methods: FOXA3 was identified in airways from patients with asthma and chronic obstructive pulmonary disease. We produced transgenic mice conditionally expressing Foxa3 in airway epithelial cells and developed human bronchial epithelial cells expressing Foxa3. Foxa3-regulated genes were identified by immunostaining, Western blotting, and RNA analysis. Direct binding of FOXA3 to target genes was identified by chromatin immunoprecipitation sequencing correlated with RNA sequencing. Measurements and Main Results: FOXA3 was highly expressed in airway goblet cells from patients with asthma and chronic obstructive pulmonary disease. FOXA3 was induced by either IL-13 or rhinovirus. Foxa3 induced goblet cell metaplasia and enhanced expression of a network of genes mediating mucus production. Paradoxically, FOXA3 inhibited rhinovirus-induced IFN production, IRF-3 phosphorylation, and IKKε expression and inhibited viral clearance and expression of genes required for antiviral defenses, including MDA5, RIG-I, TLR3, IRF7/9, and nuclear factor-κB. Conclusions: FOXA3 induces goblet cell metaplasia in response to infection or Th2 stimulation. Suppression of IFN signaling by FOXA3 provides a plausible mechanism that may serve to limit ongoing Th1 inflammation during the resolution of acute viral infection; however, inhibition of innate immunity by FOXA3 may contribute to susceptibility to viral infections associated with chronic lung disorders accompanied by chronic goblet cell metaplasia.

Original languageEnglish (US)
Pages (from-to)301-313
Number of pages13
JournalAmerican journal of respiratory and critical care medicine
Volume189
Issue number3
DOIs
StatePublished - Feb 1 2014

Keywords

  • IFN
  • Mucus
  • Rhinovirus
  • Transcription factors

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Foxa3 induces goblet cell metaplasia and inhibits innate antiviral immunity'. Together they form a unique fingerprint.

  • Cite this

    Chen, G., Korfhagen, T. R., Karp, C. L., Impey, S., Xu, Y., Randell, S. H., Kitzmiller, J., Maeda, Y., Haitchi, H. M., Sridharan, A., Senft, A. P., & Whitsett, J. A. (2014). Foxa3 induces goblet cell metaplasia and inhibits innate antiviral immunity. American journal of respiratory and critical care medicine, 189(3), 301-313. https://doi.org/10.1164/rccm.201306-1181OC